Contact
Please use this form to send email to PR contact of this press release:
PEP-Therapy receives FDA Orphan Drug Designation for PEP-010 for treatment of Pancreatic Cancer
TO:
Please use this form to send email to PR contact of this press release:
PEP-Therapy receives FDA Orphan Drug Designation for PEP-010 for treatment of Pancreatic Cancer
TO: